维普中文期刊产品整合服务
8篇 您的检索式:作者名="MARJA E"
    题名 作者 年代 出处 被引量
1The number of analyzed lymph nodes-a prognostic factor in colorectal cancer 显示文摘David E Katarina O Marja H 2007Acta Oncologica2007,46,7:1
2Improved Meth- ods for Urinary Atrazine Mercapturate Analysis-assessment of an Enzyme-linked Immunosorbent Assay (ELISA) and a Novel Liquid Chromatography-mass Spectrometry (LC-MS) Method Utilizing Online Solid Phase Extraction(SPE)显示文摘MARJA E KOIVUNEN A A KATJA D 2006Analytica Chimica Acta2006,572,:1
3Trends in the use of landscapespatial metrics as landscape indicators : a review 显示文摘Uuemaa E Mander 0 Marja R 2013EcologicalIndicators2013,28,:1
4Validity and reproducibility of a food frequency questionnaire for pregnant finnish women显示文摘Maijaliisa E Marja K Juha J 2001American Jour of Epidemiology2001,154,:1
5Metabolic and phylogenetic analysis of microbial communities during phytoremediation of soil contaminated with weathered hydrocarbons and heavy metals显示文摘Marja R T Palmroth Perttu E P Koskinen Anna H Kaksonen 2007Biodegradation2007,18,:1
6Validity and reproducibility of a food frequency questionnaire for pregnant Finnish women显示文摘Maijaliisa E Marja K Juha J 2001American Journal of Epidemiology2001,154,:1
7Land- scape metrics and indices: an overview of their use in landscape research显示文摘Uuemaa E Antrop M Roosaare J Marja R 2009Living Reviews in Landscape Re- search2009,3,1:1
8Cost-effectiveness in Clostridium difficile treatment decision-making显示文摘AIM: To develop a framework for the clinical and health economic assessment for management of Clostridium difficile infection(CDI).METHODS: CDI has vast economic consequences emphasizing the need for innovative and cost effective solutions, which were aim of this study. A guidance model was developed for coverage decisions and guideline development in CDI. The model included pharmacotherapy with oral metronidazole or oral vancomycin, which is the mainstay for pharmacological treatment of CDI and is recommended by most treatment guidelines.RESULTS: A design for a patient-based cost-effectiveness model was developed, which can be used to estimate the cost-effectiveness of current and future treatment strategies in CDI. Patient-based outcomes were extrapolated to the population by including factors like, e.g., person-to-person transmission, isolation precautions and closing and cleaning wards of hospitals. CONCLUSION: The proposed framework for a population-based CDI model may be used for clinical and health economic assessments of CDI guidelines and coverage decisions for emerging treatments for CDI.Mark JC Nuijten Josbert J Keller Caroline E Visser Ken Redekop Eric Claassen Peter Speelman Marja H Pronk 2015World Journal of Clinical Cases2015,3,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费